Dr. Joseph C. Wu, MD, PhD, is a Co-Founder of Greenstone Biosciences and a distinguished scientist specializing in cardiovascular medicine. As the Director of the Stanford Cardiovascular Institute and the Simon H. Stertzer, MD, Professor of Medicine and Radiology, he has established himself as a preeminent expert in the field. Dr. Wu obtained his MD from Yale and a PhD in molecular pharmacology from UCLA, laying the foundation for his extensive contributions to the application of induced pluripotent stem cells (iPSCs) in disease modeling, drug discovery, and regenerative medicine. With over 600 peer-reviewed articles and an impressive H-index of 142, Dr. Wu’s expertise is widely recognized, placing him among the top 0.1% highly cited researchers globally for the past seven years. His exceptional achievements have garnered prestigious awards from the NIH, DOE, DOD, NASA, and AHA.

Dr. Wu’s remarkable career spans both academia and industry, with his co-founding role at Greenstone Biosciences exemplifying his commitment to translating scientific discoveries into tangible solutions. Beyond his research accolades, Dr. Wu’s membership in prestigious institutions such as the National Academy of Inventors (NAI) and the National Academy of Medicine (NAM) reflects his influential role in shaping the future of healthcare and biomedical innovation. He was also past president of the American Heart Association (2023-2024), the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke.

Dr. Joseph C. Wu’s groundbreaking research, entrepreneurial spirit, and leadership positions highlight his dedication to improving patient care and driving scientific progress. His work continues to pave the way for novel therapies, offering hope to individuals affected by various diseases worldwide.